Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel
Drug Metabolism and Disposition · 2026-04 · 54 (4) · 100265
DOI: 10.1016/j.dmd.2026.100265 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Metabolism and Disposition, 2026-04. Verfasst von Hisakazu Ohtani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Keio University, Minato, Tokyo, Japan; School of Medicine, Keio University, Shinjuku, Tokyo, Japan; Department of Pharmacy, Keio…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Pharmacy, Keio University, Minato, Tokyo, Japan; School of Medicine, Keio University, Shinjuku, Tokyo, Japan; Department of Pharmacy, Keio University Hospital, Shinjuku, Tokyo, Japan. Electronic address: ohta…
- Faculty of Pharmacy, Keio University, Minato, Tokyo, Japan.
Zitieren
APA
Ohtani, H., & Inagaki, M. (2026). Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel. Drug Metabolism and Disposition, 54(4), 100265. https://doi.org/10.1016/j.dmd.2026.100265
Vancouver
Ohtani H, Inagaki M. Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel. Drug Metabolism and Disposition. 2026;54(4):100265. doi:10.1016/j.dmd.2026.100265
BibTeX
@article{Ohtani2026,
author = {Ohtani, Hisakazu and Inagaki, Mao},
title = {Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {4},
pages = {100265},
doi = {10.1016/j.dmd.2026.100265}
}
EUVIMED